drugset / Trial / NCT06466473

A Study to Learn How Different Forms of The Study Medicine Called Phenytoin Are Taken up Into the Blood in Healthy Adults

NCT06466473

Phase 1 Completed 35 enrolled Pfizer
RandomizedCrossoverOpen-labelHealth-services research

Summary

The purpose of this study is to understand how the different formulation of phenytoin is taken up into the blood in Healthy Adults. This study is seeking healthy adult participants. All the study participants will receive Phenytoin 50 mg chewable tablets manufactured at Ascoli and Vega Baja manufacturing site. We will measure how the phenytoin will be taken up into the blood in Healthy Adults following oral dosing of Phenytoin. This will help us determine if the Phenytoin 50 mg chewable tablets manufactured at Ascoli and Vega Baja manufacturing site are similar or not.

Timeline

Start
2024-07-03
Primary completion
2024-10-04
Completion
2024-10-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenytoin Unknown 50 mg Oral

Indications

No indication recorded.